Items Tagged ‘sonidegib’

June 13, 2014

Sonidegib Demonstrates Benefit in Advanced Basal Cell Skin Cancer in Phase II Trial


An experimental drug sonidegib (LDE225) appears to markedly shrink tumors in patients with advanced basal cell carcinoma according to results recently presented at the 2014 annual meeting of the American Society of Clinical Oncology.1 Basal cell carcinoma is the most commonly diagnosed type of skin cancer. Most cases can be treated with surgery or other types […]

View full entry

Tags: asco, basal cell cancer, basal cell carcinoma, bcc, General Skin Cancer, LDE225, News, Skin Cancer, sonidegib